Centro Hospitalar de Entre o Douro e Vouga Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2019
NCT03534895
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

ACES Entre Douro e Vouga II - Aveiro Norte | Centro Hospitalar de Entre o Douro e Vouga

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pain, Postoperative (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 6